VICTORIA, British Columbia--(BUSINESS WIRE)--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), InterSystems, a creative data technology provider dedicated to helping ...
The InterSystems/Immunoprecise partnership marks a step forward in tackling the growing data challenges in healthcare and life sciences. Geopolitical tensions, Fed ...
Despite advancements in generative AI, vector search, and multi-omics, practical applications of precision medicine remain limited, contributing to over 30% of adverse drug reactions, as noted in The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback